Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort
Renal cell carcinoma (RCC) is among the 10 most common cancer entities and can be categorised into distinct subtypes by differential expression of Krebs cycle genes. We investigated the predictive value of several targeted metabolites with regards to tumour stages and patient survival in an unselect...
Guardado en:
Autores principales: | Doreen William, Kati Erdmann, Jonas Ottemöller, Anastasios Mangelis, Catleen Conrad, Mirko Peitzsch, Evelin Schröck, Graeme Eisenhofer, Aristeidis Zacharis, Susanne Füssel, Daniela Aust, Barbara Klink, Susan Richter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/737c8718eab247f0abc5488e82bb525a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib
por: Daria A. Filonenko, et al.
Publicado: (2020) -
SDH‐deficient renal cell carcinoma: A case report associated with a novel germline mutation
por: Vassilis Milionis, et al.
Publicado: (2021) -
Paragangliomas múltiples asociados a mutación del gen SDHB: Caso clínico
por: Díaz,René E, et al.
Publicado: (2011) -
TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/HIF1α dependent manner
por: Yangbo Xu, et al.
Publicado: (2021) -
Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas
por: David Strauss, et al.
Publicado: (2022)